Although a number of other viral infections claim many more lives each year, Ebola virus is particularly feared because it spreads easily and kills swiftly and ruthlessly, before the body has time to muster an effective immune response. Now, a report that a new vaccine developed by researchers from the National Institutes of Health (NIH) appeared to protect monkeys from infection with the deadly virus is an encouraging sign of the feasibility of developing a protective human vaccine (Nature. 2000;408:605-609).
Stephenson J. Ebola Vaccine Progress. JAMA. 2001;285(3):284. doi:10.1001/jama.285.3.284
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: